dual 5alpha-reductase/androgen receptor antagonists (China Pharmaceutical University)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual 5alpha-reductase/androgen receptor antagonists (China Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitorsAndrogen Receptor degraders
TargetsAndrogen ReceptorSteroid 5 alpha reductase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChina Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A